Pros | ![]() Larger AUM within category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ||
Cons | ![]() 5Y returns in the bottom 25% of the category. ![]() 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 7/8 | 1/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 12 Years | 12 Years | ||
Fund Size | 8737 Cr | 4027 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹5000 | SIP ₹500 Lumpsum ₹5000 | ||
Expense Ratio | 0.89% | 0.91% | ||
Exit Load | 1% | 0.5% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 41 | 33 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (12.22%) Divi's Laboratories Ltd (7.55%) Lupin Ltd (5.93%) Cipla Ltd (5.69%) Dr Reddy's Laboratories Ltd (5.69%) | Sun Pharmaceuticals Industries Ltd (11.44%) Divi's Laboratories Ltd (7.21%) Max Healthcare Institute Ltd Ordinary Shares (6.5%) Cipla Ltd (4.63%) Lonza Group Ltd ADR (4.09%) | ||
No of Sectors | 1 | 3 | ||
Top 3 Sectors | Health (100%) | Health (93.89%) Basic Materials (6.11%) Government (2.58%) | ||
Equity % | 99.45% | 97.62% | ||
Debt % | - | 0.07% | ||
P/E | 37.97 | 44.9 | ||
P/B | 6.05 | 6.42 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.28% | 0.03% | ||
3-Month Return | 2.46% | 4.17% | ||
6-Month Return | 13.27% | 13.1% | ||
1-Year Return | 0.08% | 7.12% | ||
3-Year Return | 24.54% | 28% | ||
5-Year Return | 20.19% | 21.85% |
Sharpe | 1.06 | 1.36 | ||
Alpha | 0.66 | 4.73 | ||
Beta | 0.91 | 0.84 | ||
Standard Deviation | 15.05 | 13.92 | ||
Information Ratio | -0.24 | 0.72 |
Description | Nippon India Pharma Fund - Direct Plan - Growth Plan is an equity fund.The fund could potentially beat inflation in the long-run. | SBI Healthcare Opportunities Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Sailesh Raj Bhan,Kinjal Desai | Tanmaya Desai |